In 2018, breast cancer was the most common cancer in women worldwide, accounting for about a quarter of all reported cancers. When breast cancer metastasizes, the brain is a common destination.
Sep 18, 2019
0
54
Metastasizing breast cancers typically seek out the bones, lung, and brain. Brain metastases are especially dangerous; many women survive for less than a year after diagnosis. How is the cancer able to get past the blood ...
Sep 12, 2019
0
176
Brain metastases are among the deadliest tumor metastases, with a median survival period of less than one year, and the incidence of brain metastasis is rising.
Aug 19, 2019
0
2261
Treatment with the FGFR inhibitor erdafitinib in patients with metastatic bladder cancers marked by mutations in the FGFR3 gene resulted in a 40% overall response rate (ORR) and was well-tolerated, according to an international ...
Jul 25, 2019
0
1
Prostate cancer often becomes lethal as it spreads to the bones, and the process behind this deadly feature could potentially be turned against it as a target for bone-targeting radiation and potential new therapies.
May 28, 2019
0
80
Melanoma tumors that have spread to the brain are equipped to thwart immunotherapies and targeted therapies that succeed against tumors growing in other sites. Researchers at The University of Texas MD Anderson Cancer Center ...
Feb 20, 2019
0
6
Small spots on CT scans of the lungs of children with muscle cancer do not have an adverse effect on survival, according to an international research team in the Journal for Clinical Oncology. This conclusion has direct consequences ...
Feb 15, 2019
0
9
Cancer used to be thought of as a disease of the anatomy, but these days it increasingly is understood as a disease of the genes—one that theoretically can be treated with drugs engineered to target the genetic mutations ...
Nov 15, 2018
0
1
When melanoma turns metastatic, it spreads to the brain in more than 40% of patients. A study by Yale Cancer Center researchers published today in the Journal of Clinical Oncology (JCO) shows a checkpoint inhibitor immunotherapy ...
Nov 9, 2018
0
85
Results of a 275-patient, multi-national phase III clinical trial known as ALTA-1L published today in the New England Journal of Medicine and presented concurrently in the press program at the International Association for ...
Sep 25, 2018
0
5
